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Vascular endothelium, the monolayer of endothelial cells that lines the vascular tree, 
undergoes damages at the basis of some vascular diseases. Its integrity is maintained by VE-
cadherin, an adhesive receptor localized at cell-cell junctions. Here, we show that VE-cadherin is 
also located at the tip and along filopodia in sparse or subconfluent endothelial cells. We 
observed that VE-cadherin navigates along intrafilopodial actin filaments. We found that the 
actin motor protein myosin-X is co-localized and moves synchronously with filopodial VE-
cadherin. Immunoprecipitation and pull-down assays confirmed that myosin-X is directly 
associated with the VE-cadherin complex. Furthermore, expression of a dominant-negative 
mutant of myosin-X revealed that myosin-X is required for VE-cadherin export to cell edges and 
filopodia. These features indicate that myosin-X establishes a link between the actin cytoskeleton 
and VE-cadherin, thereby allowing VE-cadherin transportation along intrafilopodial actin 
cables. In conclusion, we propose that VE-cadherin trafficking along filopodia using myosin-X 
motor protein is a pre-requisite for cell-cell junction formation. This mechanism may have 
functional consequences for endothelium repair in pathological settings.  
 
The endothelium is composed of a monolayer of 
endothelial cells that lines the vascular tree. 
Hemodynamic forces, immune-mediated 
mechanisms or drug ingestion can injure the 
endothelium (35). These damages are frequently 
accompanied by a loss of endothelium integrity, an 
increase in vascular permeability and possibly by a 
detachment of endothelial cells from vascular 
walls (14). These alterations can be circumvented 
by initiating rapid repair mechanisms that re-
establish endothelium integrity and consequently 
reduce the extent of vascular diseases. The 
molecular mechanisms at the basis of the 
endothelium repair process remain elusive but it 
can be assumed that the reconstitution of 
endothelium integrity requires cell-cell 
junction rebuilding.  
In the endothelium, intercellular adherence is 
maintained by tight and adherens junctions. 
Adherens junctions are particularly crucial in 
controlling the formation and maintenance of 
interendothelial adhesion and constitute 
dynamic structures that undergo remodelling in 
migrating as well as resting cells (31). They 
are essentially composed of vascular 
endothelial-cadherin (VE-Cad) (22), an 
adhesive receptor able to elaborate homophilic 
/ homotypic interactions via its extracellular 
domain and to recruit, through its cytoplasmic 
tail, partners such as catenins (α, β, γ and 
p120). Catenins, in turn, promote the 
association of the adherens junction with the actin 
cytoskeleton, another player regulating vascular 
endothelial barrier function, by molecular 
mechanisms that are incompletely defined (8). 
Although there is a general agreement about the 
critical role played by actin filaments in the 
maintenance of mature cell-cell junctions (41;27), 
their precise role in the elaboration of premature 
adherens junctions is poorly understood. Some 
studies indicate that cells form intercellular 
junctions by a dynamic process driven by actin 
polymerization (38). It was proposed but, in our 
knowledge not firmly demonstrated, that cell-cell 
junction formation is initiated by the production of 
filopodia emanating from neighbouring cells (3; 
30; 39; 42). Filopodia lead to the elaboration of 
puncta which correspond to micro-domains where 
cadherin molecules concentrate together with their 
intracellular partners (3). These puncta spatially 
coincide with cell membrane attachment sites for 
actin filaments (2). The mechanism by which 
puncta are elaborated remains to be elucidated.  
Filopodia are highly dynamic structures filled 
with bundles of linear actin filaments (15). Their 
protrusions is driven by actin polymerization 
taking place at filament barbed ends that are 
mainly located at filopodium tips (24). The precise 
mechanisms of the nucleation and elongation of 
filopodia are controversial. In fact, two 
mechanisms for their formation have been 
proposed, each using different sets of actin-
regulating proteins. According to the “convergent 
elongation model”, filopodia are continuously 
initiated by the elongation of pre-existing 
lamellipodial actin filaments (34). This 
remodelling of actin filaments should require the 
branching activity of Arp2/3 (29), the F-actin-
bundling activity of fascin along filopodium shafts 
and the anti-capping activity of Ena/VASP at the 
barbed ends of actin filaments (4). In the opposing 
model, it was proposed that some members of the 
formin family such as Dia2 perform all these 
activities (17). Indeed, in vitro, Dia2 nucleates 
linear actin filaments, accelerates actin 
polymerization, protects barbed ends from capping 
proteins thus slowing actin depolymerization (17; 
7).  Additionally, new players such as Myosin-X 
(MyoX), able to induce filopodium formation have 
been recently discovered.  
Here, using cryo-electron microscopy, we show 
that VE-cadherin is not exclusively located at cell-
cell junctions but is also present along and at the 
tip of filopodia in sparse endothelial cells. By 
videomicroscopy, we observed that VE-cadherin 
migrates along filopodia in forward and backward 
movements. We hypothesized that motor 
proteins of the myosin family may be involved 
in the VE-cadherin transportation along 
filopodia. We considered MyoX as a potential 
candidate for promoting VE-cadherin 
trafficking.  
Myosins participate in a range of diverse 
cellular processes such as cell migration, 
membrane trafficking and formation of cellular 
protrusions. They share conserved structural 
features such as a motor domain located at 
their N-termini that can bind to actin filaments 
and hydrolyze ATP to produce movement and 
force. At their C-termini, members of the 
unconventional myosin family such as myosin-
VII, -X, -XII and -XV exhibit a myosin tail 
homology 4 domain (MyTH4) followed by a 
band 4.1 Ezrin, Radixin, Moesin (FERM) 
domain that confer them with the ability to 
perform unique cellular functions (6). A 
fascinating feature of MyoX is to use its motor 
activity to move along the intrafilopodial actin 
filaments. This probably allows MyoX to carry 
cargos along filopodia. Potential cargos are the 
β-chains of integrins recently reported to 
directly interact with the FERM domain of 
MyoX (43) and Mena/VASP that is 
synchronously transported with MyoX towards 
the tip or the base of filopodia (36). In addition 
to its motor and transport functions, MyoX 
also  promotes the formation of filopodia (5; 9; 
37). Hence, MyoX overexpression stimulates 
filopodium growth (5) whereas its knockdown 
decreases the filopodium formation (37; 9; 
28).   
Herein, we discovered that MyoX is 
colocalized with VE-cadherin in filopodia and 
moves synchronously with it. Using 
immunoprecipitation experiments and pull-
down assays, we demonstrated that MyoX 
interacts with the VE-Cad-catenin complex. 
Our data thus support a role of MyoX in the 
transportation of VE-cadherin along 
intrafilopodial actin. The forward MyoX-
mediated transport facilitates the accumulation 
of VE-Cad at the tips of filopodia where VE-
Cad can interact with partners of adjacent cells 
thus establishing preliminary cell-cell contacts. 
Formation of these early cell-cell contacts can 
be inhibited by blocking MyoX-transport 
capacity. At filopodium tips, VE-Cad linked to 
MyoX, but not engaged in homophilic 
interactions, may also be transported 
backwards to the cell body by the actin 
retrograde flow. Once at the lamellipodium 
edge, VE-Cad can be picked up again by newly 
formed filopodia. Our data suggest that MyoX-
mediated transport of the VE-Cad-catenin complex 
along filopodia is a key event required for the early 
steps of formation of cell-cell contacts, a 
process that may be of functional importance 
in endothelium repair and angiogenesis.  
 
MATERIALS AND METHODS 
Drugs and antibodies 
Fibronectin, latrunculin B, FITC- or rhodamine- 
phalloidin and mAb against α catenin and β actin 
were from Sigma-Aldrich. The mAb antibodies 
against β, γ catenins and p120 were from 
Transduction Laboratories. The affinity-purified 
pAb against human MyoX from SDI (Newark, DE, 
USA) was used in Western blot, 
immunoprecipitation and immufluorescence 
analyses. Its biochemical characterization is 
presented in Fig 1. The pAb anti-β1 integrin 
antibody was a generous gift from C. Albigès-Rizo 
(25) while the pAb antibody anti-GST was from 
GE Healthcare. The pAb antibody anti-Cad3 was 
used to immunoprecipitate the VE-Cad-based 
complex (18); (19). The anti-VE-Cad antibodies 
pAb C-19 (Santa Cruz Biotechnology) and mAb 
BV9 (11) (Abcam) were used in Western blot 
experiments. The monoclonal antibody (mAb) 
BV9 is directed against the extracellular domain 
and the polyclonal antibody (pAb) C-19 against 
the 19 amino acid-peptide at VE-Cad C-terminus. 
The secondary Cy2- or Cy3-conjugated antibodies 
were from Jackson Immunoresearch Laboratories, 
the Cy5- conjugated antibodies from GE 
Healthcare and Alexa -488, -555, -633 were 
purchased from Invitrogen.  
Cell culture 
HUVECs were isolated and cultured as previously 
described (16). Only cells on passage 2 were used. 
HeLa cells and CHO cells were respectively 
cultured in DMEM (Invitrogen) or in α-MEM 
(Invitrogen) supplemented with 10% FCS and 
antibiotics.  





A cDNA fragment containing the sequence 
encoding the FERM domain of bovine MyoX 
(K1767-V2051) (6) was produced by 
polymerase chain reaction (PCR) using the two 
following oligonucleotides: forward: 5’- 
GTGGATCCAAGTTTGAAAAGCTGGCCG
CC-3’ and reverse: 5’-
TCGACCCGGGTCACACGGAGCGCGAGG
TGCTGTA -3’. After digestion with BamHI 
and XmaI, the PCR fragment was then inserted 
into the pGEX-4T1 (GE Healthcare) to 
elaborate the vector pGEX-4T1-FERM coding 
for the FERM domain of MyoX fused with an 
N-terminus GST (GST-FERM). The protein 
GST-FERM was then produced in BL21-RIL 
(Stratagene) and purified from inclusion bodies 
dissolved in urea. The protein was in vitro 
refolded by rapid dilution in 50 mM Tris/HCl, 
pH 8 buffer containing 150 mM NaCl prior to 
be captured on a glutathione-Sepharose 
column. The 59 kDa recombinant protein was 
purified to homogeneity after elution using 
reduced glutathione. The His-tagged 
cytoplasmic domain of VE-Cad was obtained 
as previously described (40).   
Eukaryotic expression vectors  
The vector encoding GFP-MyoX was kindly 
provided R. Cheney (1). Pro-VE-Cad cDNA 
was sub-cloned in the Clontech vectors 
pAmCyan1-N1, pZsYellow1-N1 to express 
VE-Cad C-terminally fused with CFP (VE-
CFP) and YFP (VE-YFP). Additionally, Pro-
VE-Cad was also C-terminally fused with the 
tdimer 2 of DsRed using the vector pcDNA3.1- 
DsRed previously described (12). This protein,  
  
FIG. 1. Biochemical characterization of the anti-MyoX antibody. (A) The rabbit polyclonal Anti-Myosin-X 
antibody identified a polypeptide band of expected molecular mass in lysates of GFP-MyoX-expressing CHO 
cells. By contrast, no specific band was detected in lysates of GFP-expressing CHO cells indicating that no 
MyoX is expressed in CHO cells. The arrow points out intact GFP-MyoX whereas arrow heads indicate 
degradation products. (B) CHO cells expressing GFP-MyoX were immunofluorescently stained for MyoX. We 
observed that the intrinsic fluorescence of the GFP tag (Intr fluo) co-localized with the immunostaining of MyoX 
(Anti- MyoX) thus attesting the specificity of the antibody for MyoX. 
 
designated as VE-DSR, remained monomeric 
because of its fusion with a tandem dimer of 
DsRed. Indeed, formation of intramolecular 
contacts between the tandem DsRed moieties 
within the same polypeptide prevents protein 
oligomerization (12).  Additionally, the tandem 
DsRed motif rendered VE-DSR resistant to 
photobleaching and consequently perfectly well-
adapted to videomicroscopy experiments. The 
characterization of these fluorescent proteins is 
presented in Fig 2. The specificity of VE-DSR and 
GFP-MyoX localization in double-fluorescently 
transfected HUVECs was also controlled (Fig 3). 
To express in HUVECs and CHO cells the protein 
GST-FERM-DSR, the eukaryotic expression 
vector pcDNA3.1-GST-FERM-DSR was 
constructed by amplifying by PCR the cDNA 
coding for the GST-FERM protein. This was 
performed using the E. coli expression vector 
pGEX-4T1-FERM and the primers 5’- 
CACATCTAGAATGTCCCCTATACTAGGTTA
T 3’ and 5’-
GCAGATATCACGGAGCGCGAGGT -3’. 
Following digestion by Xba1 and EcoRV, this 
PCR fragment was then introduced in the vector 
pcDNA 3.1- DSRed to generate the eukaryotic 
expression vector pcDNA-GST-FERM-DSR 
coding for GST-FERM-DSR. Similarly, to express 
in HUVECs and CHO cells, the protein GST-
DSR, the eukaryotic expression vector pcDNA-
GST-DSR was elaborated by amplifying the 
cDNA coding for GST. This was made using the  
 
 





C-3’. Following digestion by Xho1 and BamH1, 
this fragment was inserted into the eukaryotic 
expression vector pcDNA- DSRed to generate the 
vector pcDNA-GST-DSR coding for GST-DSR.  
Transfections  
Once seeded on glass coverslips or Labtek I 
(Nunc, Rochester, NY), HUVECs were transiently 
transfected using 200 nM polyethylenimine (PEI, 
Sigma-Aldrich) added in cell medium culture 
devoid of serum during 45 min at 37°C. Hela and 
CHO cells were transfected using Exgen 500 
(Euromedex) according to manufacturer protocol. 
Immunoprecipitation and GST pull-down 
assays  
For pull-down assays, cell lysates (57 cm2) were 
incubated overnight at 4°C with 200 µl of 
glutathione-beads coupled to either GST or GST-
FERM proteins in the presence or absence of 100 
µM LaB. After three washing steps in lysis buffer 
(10 mM PIPES, pH 7.7 containing 100 mM NaCl, 
300 mM sucrose, 3 mM MgCl2, 1 mM EDTA, 0.5 
% NP40), pulled-down proteins were eluted with 
100 µl washing buffer containing 20 mM reduced 
glutathione and then boiled with Laemmli buffer 
containing β-mercaptoethanol.  
For immunoprecipitations, endothelial cell or 
CHO monolayers (57 cm2) were lysed 5 min at 
4°C and scrapped in 500 µl RIPA buffer (PBS pH 
  
FIG. 2. Characterization of the fluorescent proteins VE-CFP, VE-YFP and VE-DSR. (A) Biochemical 
characterization of VE-CFP, VE-YFP and VE-DSR. cDNA constructs expressing CFP, VE-CFP, YFP, VE-YFP, 
DSR and VE-DSR were transfected in CHO cells. At 24 h post tranfection, lysates of these transfected cells were 
analysed by Western blot. The anti-VE-Cad mAb BV9 antibody identified polypeptide bands of 165, 150 and 
190 kDa corresponding to the expected sizes for VE-CFP, VE-YFP and VE-DSR respectively. These bands were 
not detected in lysates of CHO cells expressing CFP, YFP and DSR. In HUVECs used as a control, the wild type 
form of VE-Cad was detected as a 135 kDa polypeptide band. (B) Co-immunoprecipitation of VE-DSR with 
catenins. Anti-VE-Cad (IP BV9) immunoprecipitation was performed on VE-DSR-expressing CHO cells prior 
to be resolved on a 4-12% gradient gel, electro-transferred and probed successively for VE-Cad, p120 and β-cat. 
As control, an immunoprecipitation performed on VE-DSR-expressing CHO cells using rabbit non-immune IgG 
(Ctr) was analyzed in parallel. Molecular weight markers are given at the margin of the panel. (C) Localization 
at cell-cell contacts of exogenous VE-CFP, VE-YFP and VE-DSR transiently expressed in HUVECs. HUVECs 
expressing VE-CFP, CFP, VE-YFP, YFP, VE-DSR and DSR were immunofluorescently stained for VE-Cad and 
observed by confocal microscopy. Then, the intrinsic fluorescence of the CFP, YFP and DSR tags (Intr fluo) was 
compared to the immunofluorescent staining (Anti-VE-Cad). As expected, the three fluorescent VE-Cad proteins 
were mainly expressed at cell-cell junctions and on filopodia recapitulating the staining pattern of endogenous 
VE-Cad. By contrast, the proteins CFP, YFP and DSR did not present a specific localization. Bars = 20 µm. 
 
 
7.4, 150 mM NaCl, 1 mM MgCl2, 0.5 % 
Deoxycholate, 1% Triton-X100, 0.1% SDS, 1 mM 
ATP, containing a protease inhibitor cocktail). 
Prior pre-clearing, cell lysates were treated with 
latrunculin B as mentioned for pulled-down 
experiments. Pre-cleared lysates were 
immunoprecipitated with the polyclonal anti-
MyoX (4 µg) or anti-VE-Cad (4 µg) antibodies 
coupled to 1.6 mg of protein-A sepharose (Sigma). 
Immune complexes were washed three times with 
RIPA buffer prior to be eluted with 2X Laemmli  
 
 
buffer 10 min at 100°C and reduced with β-
mercaptoethanol. 
SDS-PAGE and Western blot analysis 
MyoX immunoprecipitations were separated by 
electrophoresis in MOPS buffer (Biorad) on pre-
cast Criterion XT 4-12 % gradient Bis-Tris gels 
(BioRad). The gels were transferred 1h (300 mA) 
to Immobilon membrane (Millipore) using a Tris-
glycine buffer. Then, membranes were blocked 
with 5% non-fat dry milk and proteins from total 
cell extracts, immunoprecipitates or pull-down 
assays were detected by specific primary 
  
 
FIG.  3. Specificity of localization of VE-DSR and GFP-MyoX in double-fluorescently transfected HUVECs. To 
control the specificity of GFP-MyoX localization, HUVECs co-expressing either GFP-MyoX and VE-DSR 
(panels at left) or GFP-MyoX and DSR (middle panels) were analyzed in green and red fluorescence channels. 
Using ImageJ, the fluorescent intensity (I) of GFP-MyoX spots (delimited by ellipses) were measured and 
compared to the fluorescent intensities of the superimposed areas in the other channel. While the mean value for 
I GFP-MyoX/ I VE-DSR ratio is ranging 1 (20 measurements from 5 images), that of IGFP-MyoX/ IDSR ratio varied 
between 3.105 – infinite (20 measurements from 5 images). Similarly, to control the specificity of VE-DSR 
localization, HUVECs co-expressing GFP and VE-DSR were analyzed in parallel for fluorescent localization 
(panels at right). While the mean value for I VE-DSR / I GFP-MyoX ratio is ranging 1, that of IVE-DSR/ IGFP ratio varied 
between 1.105 – to infinite (20 measurements from 5 images). From ratio-metric quantification, it can be 
deduced that the localization of VE-DSR or GFP-MyoX is not disturbed by GFP- and DSR- associated 
fluorescence, respectively.   
 
antibodies as specified followed by horseradish 
peroxidase-conjugated goat anti-mouse or goat 
anti-rabbit immunoglobulin reagents (Sigma). The 
immunoreactive bands were revealed using ECL 
Western blot detection kit (Amersham).  
Immunofluorescence labelling of fixed 
HUVECs  
For all immunostainings except MyoX, cells were 
fixed for 20 min with 3% paraformaldehyde, 
permeabilized using 0.5% Triton X-100 for 3 min. 
Protocol to visualize MyoX is adapted from (23). 
Briefly, after two rinsing steps in calcium- and 
magnesium-containing PBS, cells kept 3 min on 
ice were pre-permeabilized 3 min in MyoX-
FBuffer (10 mM PIPES, pH 6.8, 50 mM NaCl, 
3mM MgCl2, 300 mM Sucrose) with 0.5% Triton 
X-100 containing an inhibitor cocktail (Roche) 
prior to be fixed 20 min at room temperature with 
chilled MyoX-FBuffer containing 4% PFA. After a 
blocking step in 5% fetal calf serum-containing 
PBS during 1 hour, cells were incubated with 
primary antibodies overnight at 4°C and 
subsequently incubated with appropriate secondary 
antibodies. 
Microscopy  
For videomicroscopy experiments, once seeded on 
Lab-Tek I chambers, HUVECs and HeLa cells 
were maintained in phenol red-deprived-M199 
(supplemented with low serum growth supplement, 
20% fetal calf serum and  
 
 
antibiotics) and in phenol red-deprived-DMEM 
(supplemented with 10% fetal calf serum and 
antibiotics) cell culture media, respectively. 
Confocal videomicroscopy images were 
collected on a Zeiss LSM510 confocal 
microscope equipped with a heating workplate, 
a humidifier, a CO2 delivery system and using 
either a ×63 Plan Apochromat objective (oil, 
1.45 NA, pH 3) or a ×40 Plan-Neofluar 
objective (oil, 1.30 NA, pH3) (Photonic 
microscopy/Cellular Imaging platform of 
Institut Albert Bonniot, Grenoble, France). 
Time between images was typically 1-3 min. 
Phase contrast images were always co-
acquired with YFP in order to reduce the delay 
between frames. Epifluorescence 
videomicroscopy images were collected 
sequentially on an IX71 (Olympus) 
microscope equipped with a heating workplate, 
a humidifier and a CO2 delivery system and 
using a ×40 Plan Apochromat (oil, 1.0 NA, 
pH3) or a ×40UApochromat (oil, 1.35 NA) 
objectives and an ORCA-ER camera 
(Hamamatsu). Typical time between frames for 
epifluorescence videomicroscopy varies from 
100 ms to 1 min. In general, cells were imaged 
over periods of 1-180 min. Confocal images on 
fixed cells were collected sequentially using a 
Leica TCS-SP2 confocal microscope (Leica 
Manheim, Germany) equipped with a ×63 
HCX Plan Apochromat objective (oil, 1.4 NA). 
Epi-fluorescence images on fixed cells were 
acquired using an Axioplan 2 microscope (Zeiss) 
equipped with a ×100 AchroPlan (oil, 1.25 NA) or 
×50 AchroPlan (oil, 0.9 NA) and an AxioCam MR 
camera. Fluorescence filters were chosen and 
tested on each combination of plasmid 
constructions to abolish fluorescence overlap. Only 
microscope proprietary softwares were used to 
acquire images.  
Image processing 
Each time lapse confocal image corresponds to the 
projection of four 500 nm optical sections. Movies 
were treated and edited using ImageJ and Adobe 
After Effects 6.5 and exported using Quick Time 
Pro 7.4 with H.264 codec. For fixed cells, images 
were treated and mounted using Adobe Photoshop 
CS 2 and Illustrator CS 2.  
Patch velocity measurements and statistics  
Kymographs were generated using ImageJ and 
Multiple kymograph plugin. In fact, kymographs 
were generated by analyzing several filopodia 
from different HeLa cells. Two typical 
kymographs illustrating the forward (A) and 
backward (B) movements of GFP-MyoX are 
shown in Fig 4. The two-sample t-test was used to 
determine if the average rates for forward 
movements of VE-DSR and GFP-MyoX, 
derived from velocity histograms were 
equivalent.  
Cryo-electron microscopy 
HUVECs were plated on holey carbon 
fibronectin pre-coated nickel grids. After a 24 
hour post-seeding time, cells were fixed with 
paraformaldehyde at room temperature. VE-
Cad was then stained with the monoclonal 
antibody BV9 and protein A conjugated to 10 
nm-colloidal gold. Cells were submitted to a 
post-fixation step using glutaraldehyde. For 
cryoEM observation of VE-Cad, grids were 
rapidly plunged into a liquid ethane bath 
cooled with liquid nitrogen (Leica EM CPC, 
Vienna, Austria) and maintained at a 
temperature of approximately –170 °C using a 
cryo-holder (Gatan, Pleasanton, CA) prior to 
be observed using a FEI Tecnai F20 electron 
microscope (Eindhoven, NL) operating at 200 
kV under low-dose conditions. Images were 







FIG. 4. Kymographs illustrating the forward and 
backward movements of GFP-MyoX. (A) Kymograph 
of a selected filopodium emanating from GFP-MyoX-
expressing HeLa cells imaged at 25°C using a ×40 lens 
(N.A. 1.35), a pixel size of 162 nm, a frame rate of 5.6 
images.s-1 over 300 frames. Numerous faint tracks 
sloped down towards the filopodium tip illustrating the 
forward movement of GFP-MyoX. Note that patches of 
GFP-MyoX move at a relatively similar constant 
velocity. (B) Kymograph of a selected filopodium 
emanating from a GFP-MyoX-expressing HeLa cell 
imaged as in Fig 4 A. Two faint tracks sloped down 
towards the filopodium base illustrating the backward 
movement of MyoX. 
Filopodia establish the preliminary 
endothelial cell-cell contacts 
To elucidate the role of filopodia in the 
formation of early endothelial cell-cell 
contacts, HUVEC monolayers were co-stained 
for VE-cadherin and actin. As expected, it 
revealed that the most mature junctions 
exhibited a continuous thin VE-Cad labelling 
close to circumferential actin cables (Fig 5, 
middle and upper panels). But, in preliminary 
cell-cell contacts, VE-Cad labelling exhibited a 
characteristic zigzag staining dotted with 
residual randomly distributed intercellular gaps 
(Fig 5, middle and lower panels). These 
newly formed intercellular contacts were 
composed of multiple protrusions where VE-
Cad co-localized with radially oriented actin 
fibers (Fig 5, lower panels). Cryo-electron 
microscopy confirmed and showed more 
precisely that, in subconfluent HUVECs, VE-
Cad molecules are distributed along and at the 
tips of protrusions. The electron micrographs 
also revealed the presence of actin filaments 
aligned in tight parallel bundles within these 
protrusions that, consequently, could be 




VE-Cad molecules navigate on filopodia 
We then used videomicroscopy to examine 
whether VE-Cad is able to move along filopodia. 
To visualize VE-Cad, various constructs coding 
for VE-Cad C-terminally fused to fluorescent 
DsRed (red), YFP (yellow), CFP (cyan) proteins 
were elaborated to express VE-DSR, VE-YFP or 
VE-CFP, respectively (Fig 2). It must be noted that 
these cDNA constructs were designed to produce 
fluorescent VE-Cad molecules that remained 
monomeric and interact with catenins (report to 




FIG. 5. Localization of VE-Cad in subconfluent 
HUVECs. Images on the central row show a HUVEC 
monolayer immunolabelled for VE-Cad (red, left), actin 
(green, centre) and merge (right). The selected 
enlargements of a mature cell-cell junction (continuous 
frame) and an immature junction (dotted frame) are 
shown at the upper and lower rows, respectively. In 
mature junctions, VE-Cad and cortical actin fibers are 
located at the cell circumference (arrow-heads, upper 
row). By contrast, in immature junctions, VE-Cad co-
localizes with radial actin fibers along filopodial 
extensions bridging adjacent cells (arrows, lower row). 
Bars: 2 µm (upper); 10 µm (middle) and 5 µm (lower).  
 
At subconfluency, HUVECs emitted numerous 
filopodia that formed bridges between 
neighbouring cells (Fig 5). In premiminary 
confocal videomicroscopy experiments performed 
on VE-YFP-expressing HUVECs, at a frame rate 
of 1 image.min-1, we observed that some patches 
of VE-YFP adopted linear trajectories by moving 
along pre-established filopodia (Fig 7, See 
supplementary data, Movie 1). By contrast, no 
such movement was seen for YFP (Fig 7, See 
supplementary data, Movie 2).  In a second type 
of experiments, sparse living HUVECs transiently 
expressing VE-DSR were observed by 
videomicroscopy using a frame rate of 3 images.s-1 
(Movie 3). Under these conditions, isolated cells 
emitted numerous free filopodia along which faint 
VE-DSR particles moved rapidly. VE-DSR 




FIG. 6. Localization of VE-Cad at the surface of 
HUVEC filopodia by electron microscopy. Living 
HUVECs were seeded on electron microscopy 
holey grids and grown for 24 hours. After fixation 
without permeabilization, cells were successively 
marked with mAb BV9 antibody and protein-A 
gold particles to reveal the presence of VE-Cad at 
the cell surface. They were then vitrified for 
observation. Electron micrographs revealed 
filopodia of various diameters and lengths 
connecting adjacent cells (micrographs I and VI, 
bars = 1 µm). Higher-magnification images show 
gold particles dispersed along the length 
(micrographs II, III, IV and VII; bars = 100 nm) 
and at the tip of filopodia (micrograph V; bar = 100 
nm). This indicates that VE-Cad is distributed over 
the surface of filopodia. Furthermore, on large as 
well as thin filopodia, underneath the plasma 
membrane, the network of actin fibers could be 
observed parallel to the filopodium axis 
(micrograph VII). 
 
rapid in Movie 3 than those observed by slow 
frame rate confocal videomicroscopy in Movie 
1. By contrast, such a rapid traffic was not 
observed in HUVECs overexpressing control 
DSRed (Movie 4), thereby indicating that 
trafficking is due to the VE-Cad moiety linked 
to the transportation machinery. Altogether, 
the data suggest that VE-Cad molecules 
navigate on filopodia probably 
  
FIG. 7. Selected sequences showing VE-YFP moving along filopodia. Subconfluent HUVECs were transiently 
transfected with the plasmids expressing either VE-YFP or YFP. At 17 h post transfection time, confocal 
videomicroscopy images were taken every min for 1 hour both in phase contrast to see the filopodia and in the 
yellow fluorescence channel. Panels corresponding to VE-YFP-expressing HUVECs (Left) showed two distinct 
patches, indicated by arrow-heads, moving sequentially along two filopodia.  Report to Movie 1 in 
Supplementary data. By contrast, no YFP was detected along filopodia as illustrated in panels corresponding to 
YFP-expressing HUVECs (right). Report to Movie 2 in Supplementary data. Bars = 10 µm 
 
through an actin-dependent mechanism excluding the possibility that membrane diffusion be at the 
basis of VE-Cad motion. Moreover, as shown thereafter, the fast and slow velocities observed for VE-
Cad particles corresponded to forward (towards the filopodium tip) and backward (towards the 




FIG. 8. Expression of MyoX in HUVEC and HeLa cells. (A) Detection of endogeneous MyoX by Western blot. 
HUVEC and HeLa lysates were analysed by Western blot using the anti-MyoX pAb antibody. In HUVECs as 
well in HeLa, the antibody detected a 240 kDa band corresponding to the expected size of MyoX and several 
bands of lower molecular mass corresponding to MyoX degradation (6). Higher amounts of MyoX were detected 
in HeLa cells compared to HUVECs. (B) Partial co-localization of endogenous MyoX and VE-Cad along 
filopodia in subconfluent HUVECs. Subconfluent HUVECs were double labelled for MyoX (left) and VE-Cad 
(centre) with pAb anti-MyoX, mAb anti-VE-Cad BV9, Alexa-555-labelled goat-anti-rabbit and Alexa-488-
labelled goat-anti-mouse antibodies and Hoescht. The merged image is at the right. Arrows pointed out VE-Cad 
patches co-localized with MyoX while arrowheads indicated cell-cell junctions where VE-Cad and MyoX did 
not co-localized. Bar: 20 µm.  
 
The motor protein myosin-X interacts with 
the VE-Cad-catenin complex 
As VE-Cad is able to move along filopodia, 
we hypothesized that VE-Cad is directly or 
indirectly linked to intrafilopodial actin fibers 
through an actin motor protein. Myosins 
constitute a family of actin-dependent motor 
proteins that support protein carrier function. 
Endothelial cells expressed several myosin 
family members such as myosin-II, -VII and -
X. The unconventional myosin-X (MyoX) is a 
potential candidate for VE-Cad transport since 
it is located at the filopodium tips of various 
non-endothelial cell lines (5).   
Analysis of HUVEC lysates by Western blot 
using anti-MyoX antibody revealed the 
presence of a 240 kDa band corresponding to 
full-length MyoX (Fig 1 and 8 A). Additional 
bands with molar weights ranging 100-130 
kDa were also detected because of MyoX 
susceptibility to proteolysis (6). 
Immunofluorescence labeling of subconfluent 
HUVECs effectively showed a punctuate 
staining of MyoX that partially co-localized 
with VE-Cad (Fig 8 B). After a careful 
scrutiny of immunofluorescence images, 
MyoX appeared associated with 
extrajunctional VE-Cad and not with 
junctional one (Fig 8 B).  
We speculated that MyoX interacts, at least 
temporarily, with VE-Cad thus allowing its 
cellular transport along intrafilopodial actin 
fibers. To verify this hypothesis, different 
approaches such as immunoprecipitation and 
pull-down assays were used. Hence, analyses 
of VE-Cad immunoprecipitates by Western 
blot using an anti-MyoX antibody revealed the 
presence of the 240 kDa form of MyoX (Fig 9 
A). Conversely, anti-MyoX 
immunoprecipitation showed association of 
MyoX with the uncleaved form of VE-Cad 
(Fig 9 B). To confirm immunoprecipitation 
data, GST pulldown assays were performed on 
HUVEC extracts using the FERM (band 4.1 
Ezrin, Radixin, Moesin) domain of MyoX 
previously described to be involved in cargo 
binding (43), (28) and N-terminally-coupled to 
GST (GST-FERM). The GST-FERM fusion 
protein was first assayed for its capacity to 
bind integrin β chains, as 
  
FIG. 9. Association of MyoX to the VE-Cad-based complex. (A, B) Co-immunoprecipitations of endogenous 
MyoX with endogenous VE-Cad in HUVECs. Anti-VE-Cad (IP VE, A) and anti-MyoX (IP MyoX, B) 
immunoprecipitations were resolved on 4-12% gradient gels, electro-transferred and probed successively for VE-
Cad and MyoX. As controls, an aliquot of whole cell lysate (input) and immunoprecipitations performed on 
HUVEC lysates using rabbit non-immune IgG (Ctr) were analyzed in parallel. Note that Anti-VE-Cad IP (A) and 
input analysis by Western blot (B) revealed the presence of a 100 kDa truncated form of VE-Cad (VE-Cadtr). 
Molecular weight markers are given at the margins of each panel. (C) Interaction of MyoX with the VE-Cad 
complex through its FERM domain. GST or GST-FERM immobilized on glutathione beads was incubated with 
either HUVEC lysates or with buffer. Pull-down assays were revealed with the anti-VE-Cad antibodies directed 
against the extracellular domain (Extra, mAb BV9) or the cytoplasmic domain (C-Ter, pAb C-19). Lower panel: 
Coomassie staining of GST proteins used in each pull-down assay. For comparison, aliquots of whole cell 
lysates and pull-down assay controls performed without lysate were analyzed in parallel. Note that the antibody 
C-19 raised against the 19 amino acid C-terminal peptide of VE-Cad did not recognize VE-Cadtr indicating that 
the truncated form of VE-Cad is cleaved at its C-terminus. Only the uncleaved form of VE-Cad is co-
precipitated with the FERM domain of MyoX. (D) Co-precipitation of catenins with VE-Cad by the FERM 
domain of MyoX. GST and GST-FERM pull-down assays performed on HUVEC lysates were probed with VE-
Cad, α-catenin (α-cat), β-catenin (β-cat) and p120 antibodies. All these proteins were detected in pull-down 
assays performed with GST-FERM but not with GST alone. (E) The interaction between the VE-Cad complex 
and MyoX does not require actin fibers. GST and GST-FERM pull-down assays performed on HUVEC lysates 
treated (+) or not (-) with latrunculin B (LaB) were sequentially immunoblotted for VE-Cad with C-19 pAb and 
for β-actin with anti-β-actin mAb. For comparison, an aliquot of whole cell lysate was analyzed in parallel. 
Lower panel: Coomassie staining of GST proteins. In pull-down assays, VE-Cad was precipitated with the 
domain FERM of MyoX even in the absence of actin. (F) The recombinant GST-FERM protein interacts with 
the β1 chain of integrins. GST and GST-FERM pull-down assays performed on HUVEC lysates were 
immunoblotted for the β1 chain of integrins with the pAb anti-β1 integrin antibody. For comparison, an aliquot 
of whole cell lysate (Input) was analyzed in parallel. In pull-down assays, β1 chain of integrins was precipitated 
with the domain FERM of MyoX. 
  
FIG. 10. Selected sequence focusing on the coordinated backward movements of MyoX and VE-Cad. 
Subconfluent HUVECs, transiently co-transfected with plasmids expressing GFP-MyoX and VE-DSR, were 
observed by videomicroscopy at 17 h post transfection at a frame rate of 1 image/ 3s. Full arrow-heads and 
arrows indicate moving and immobile patches, respectively, for VE-Cad and MyoX. Bars = 10 µm.
previously reported for MyoX (41). Pull-down 
assays, performed on HUVEC extracts, 
revealed that GST-FERM retained the 
capability to interact with the integrin β1 chain 
whereas GST did not (Fig 9 F). Importantly, 
GST–FERM specifically interacted with the 
uncleaved 135 kDa form of VE-Cad and not 
with the intracellular truncated 100 kDa form 
present in HUVEC lysates (Fig 9 C). 
Moreover, GST-FERM was able to pull down 
the VE-Cad cytoplasmic partners α-, β- or 
p120- catenins from HUVEC lysates (Fig 9 D). 
By contrast, it did not interact with a 
recombinant fragment that overlapped the 
amino stretch A630-Y784 corresponding to the 
cytoplasmic region of VE-Cad truncated at its 
N-terminus (40) (data not shown). This 
indicates that MyoX associates with one 
element of the VE-Cad-catenin complex 
without disturbing its integrity. In addition, 
actin, probably incorporated in filaments, was 
also co-precipitated with GST-FERM and not 
with GST (Fig 9 E). To exclude the possibility 
that actin filaments link the VE-Cad-catenin 
complex to MyoX, filaments were 
depolymerized in cell extracts with the actin 
monomer-sequestering drug latrunculin B 
(LaB) (13). In these conditions, no actin was 
precipitated in GST-FERM pull-down assays 
(Fig 9 E). However, VE-Cad was still pulled-
down with GST-FERM indicating that actin 
cables were not involved in the link between 
the VE-Cad-catenin complex and MyoX. 
Finally, substitution in pull-down assays of the 
FERM domain of MyoX by the FERM domain 
of moesin did not precipitate VE-Cad attesting 
that the results obtained with the FERM 
domain of MyoX are specific (Data not 
shown). Altogether, our results establish that 
the FERM domain of MyoX interacts with the 
VE-Cad-catenin complex.  
 
MyoX transports VE-Cad along filopodia 
To examine the temporal and spatial co-
localization of VE-Cad and MyoX, VE-DSR 
and MyoX N-terminally fused with GFP (GFP-
MyoX (6)) were co-expressed in HUVECs. 
We first controlled the specificity of the 
localization of VE-DSR and GFP-MyoX prior 
to imaging (Fig 3). Using videomicroscopy, 
we noticed that some patches of GFP-MyoX 
remained immobile at filopodium tips while 
others started from the tips of filopodia 
dragging VE-DSR clusters backwards (Fig 10, 
See Supplementary data, Movie 5). This 
backward movement was relatively slow and 
could be observed by videomicroscopy using a 
frame rate of 1 image/ 3 s. In addition, 
movements of VE-DSR and MyoX patches 
towards the tips of filopodia (forward motion) 
were also observed. But, the high displacement 
rate at 37°C in HUVEC rendered the 
observation of these movements difficult. To 
palliate this inconvenience, we chose to image 
VE-DSR and GFP-MyoX motilities in HeLa 
cells. These experiments were performed at 
25°C to reduce the movement rate (21) since 
HeLa cells, by contrast to HUVECs, tolerate 
this temperature. Under these selected 
conditions, HeLa exhibited 10-20 µm long 
filopodia and it was possible to individually 
track VE-DSR and GFP-MyoX patches  over 
times ranging 50-100 s (See Supplementary 
data, Movies 6 and 7). Hence, Movie 7 shows 
a single patch of GFP-MyoX that co-localized 
with a single VE-DSR patch and moved 
synchronously with it on a given filopodium.  
Both patches moved backwards prior to 
moving towards the distal tip of the filopodium 
(full arrow-heads). It could be noticed that the 
backward movement was frequently 
interrupted by episodes of pausing (See 
Supplementary data, Movie 7). Movie 7 also 
highlights the difference existing between 
forward and backward velocities. Altogether, 
our results on MyoX and VE-Cad co-
localization and co-migration along 
  
FIG. 11. Velocity histograms for forward and backward movements of VE-DSR and GFP-MyoX patches. 
Histograms corresponding to the forward movements of VE-DSR (A) and GFP-MyoX (B) patches were 
generated from 115 and 129 measurements respectively while those corresponding to the backward movements 
of VE-DSR (C) and GFP-MyoX (D) patches from 38 and 41 measurements respectively. At the top right, the 
means +/- standard deviations are indicated. HeLa cells were imaged at 25°C using a ×40 lens (N.A. 1.35), a 
pixel size of 162 nm and a frame rate ranging 3-5 images.s-1. 
  
filopodia strongly suggest that VE-Cad is 
transported by a MyoX-dependent mechanism.
Frequently, VE-DSR / GFP-MyoX patches 
moving forward and backward were 
individually observed on the same filopodium. 
To obtain a global vision of protein 
movements along a given filopodium, location 
of each individual patch was plotted versus 
time to generate a kymograph. In this kind of 
projection, each patch movement appears as an 
individual line directed towards the tip of 
filopodium for forward movement and towards 
filopodium base for backward movement (Fig 
4). The velocity of a large number of 
individual patches visualized by single-channel 
videomicroscopy could be derived from the 
slope of the tracks in kymographs and reported 
in histograms showing the velocity profile for 
each fusion protein (Fig 11). Hence, we 
calculated that VE-DSR moved at an average 
forward rate of 694 +/- 174 nm.s-1 (115 
measurements on 35 filopodia)(Fig 11 A) and 
at an average backward rate of 27 +/- 10 nm.s-1 
(38 measurements on 22 filopodia) (Fig 11 C). 
Similarly, GFP-MyoX kymographs showed 
that GFP-MyoX moved forward at an average 
velocity of 649 +/- 218 nm.s-1 (129 
measurements on 15 filopodia) (Fig 11 B) and 
backwards at 25 +/- 10 nm.s-1 (41 
measurements on 22 filopodia) (Fig 11 D) as 
previously described) (21). Statistically, 
according to the two-sample t-test, the mean 
rates for the forward movements of VE-DSR 
and GFP-MyoX are equivalent (p>0.05). 
 
Double-channel videomicroscopy 
experiments were also performed on HeLa co-
expressing GFP-MyoX and VE-DSR to 
visualize the synchronous movements of the 
two fluorescent proteins. Hence, in Fig 12 A 
and B, dual kymographs showed two selected 
GFP-MyoX and VE-DSR particles that 
exhibited synchronous backward (pointed out 
by arrowheads) and forward (pointed out by 
arrows) motions. These experiments confirm 
the co-transport of GFP-MyoX and VE-DSR 
along filopodia in both directions. Because of 
the known functions of MyoX as a cargo for 
protein transport and as an actin motor protein, 
it is likely that MyoX mediates the 
transportation of the VE-Cad complex along 
intrafilopodial actin cables. 
 
MyoX FERM domain overexpression 
blocks the transportation of VE-CFP 
We next tried to test the functional role of 
MyoX-mediated transport of VE-Cad. We 
opted for a dominant-negative approach by 
constructing the fusion GST-FERM-DSR 
protein consisting of the GST moiety, the 
FERM domain of MyoX and DSR (Fig 13 A). 
This fluorescent protein was designed to retain 
the cargo function but to remove the motor 
function of MyoX. The fusion protein GST-
DSR, composed of the GST and the DSR 
entities, was also elaborated and used as a 
control (Fig 13 A). The cDNA constructs 
coding for GST-FERM-DSR and GST-FERM 
were transiently transfected in CHO cells and 
the expression of recombinant proteins was 
analyzed by Western blot using the polyclonal 
anti-GST antibody. As expected, a 110 kDa 
and a 80 kDa bands were detected in the GST-
FERM-DSR and GST-DSR transfectants, 
respectively (Fig 13 B). Moreover, GST-
FERM-DSR interacted with VE-Cad as 
attested by immunoprecipitation experiments 
performed on CHO cells co-expressing VE-
Cad and GST-FERM-DSR. By contrast, GST-
DSR did not (Fig 13 C).  
To prove that VE-Cad sequestration by GST-









FIG.   12. MyoX and VE-Cad dynamics in living 
HeLa cells. Synchronous kymographs of a selected 
filopodium emanating from HeLa cells co-
expressing VE-DSR (A) and GFP-MyoX (B) 
imaged at 25°C using a 40x lens (N.A. 1.35), a 
pixel size of 162 nm and a frame rate of 3 images / 
10s. The VE-DSR kymograph showed a patch that 
(1) remained stationary (vertical track), (2) globally 
moved backward towards the filopodium base 
(arrowheads), (3) abruptly changed of direction, 
and (4) moved forward (arrows) prior to reach the 
filopodium tip. Note that the backward phase was 
frequently interrupted by pausing events, thus 
creating a stair-shaped track (arrowheads). This 
track was perfectly detected in the corresponding 
GFP-MyoX kymograph illustrating the 
synchronous movement of VE-DSR and GFP-
MyoX patches on a given filopodium. 
 
 
transfected VE-Cad-expressing CHO cells with 
plasmids coding for GFP-MyoX and either 
GST-DSR or GST-FERM-DSR. Anti-MyoX 
immunoprecipitations on cell lysates revealed 
that the amount of VE-cadherin co-precipitated 
with MyoX remained nearly unchanged in the 
presence or absence of GST-DSR (Fig 13 D). 
By contrast, a slight and reproductive decrease 
in the VE-Cad amount immunoprecipitated 
with MyoX was observed in the presence of 
GST-FERM-DSR suggesting that GST- 
  
FIG.   13. Biochemical characterization of the recombinant proteins GST-FERM-DSR and GST-DSR. (A) 
Schematic representation of MyoX and its derived fragments. The recombinant fragment GST-FERM-DSR was 
designated to keep the capacity of MyoX to interact with VE-Cad via its FERM domain. The GST-DSR 
recombinant fragment was used as a control. (B) Expression of GST-DSR and GST-FERM-DSR. CHO cells 
were transfected with either GST-DSR (lanes 2 and 5) or GST-FERM-DSR (lanes 3 and 6) or not (lanes 1 and 
4).  Expression of GST-DSR and GST-FERM-DSR in CHO cells was verified by Western blot using the anti-
GST antibody. This antibody recognized a 80 kDa and a 110 kDa bands corresponding to GST-DSR and GST-
FERM-DSR, respectively. Additionally, it also unspecifically recognized a protein present in CHO lysates (star). 
(C) GST-FERM-DSR interacts with VE-cadherin. Anti-VE-Cad immunoprecipitations (IP VE-Cad) were 
performed on CHO cell lysates co-expressing either VE-Cad and GST-FERM-DSR or VE-Cad and GST-DSR 
using the mAb anti-VE-Cad BV9. As controls, aliquots of whole CHO lysates (inputs) and immunoprecipitations 
performed on CHO lysates using mouse non-immune IgG (IP Ctrl) were analyzed in parallel. A 110 kDa band 
corresponding to GST-FERM-DSR was detected in the anti-VE-Cad immunoprecipitate, indicating that GST-
FERM-DSR is able to interact with VE-Cad. The anti-GST antibody recognized as in Fig 13 B GST-DSR and 
GST-FERM-DSR as well as an unspecific protein present in CHO cell lysates (star). Molecular weight markers 
are given at the left margin. (D) Cellular VE-Cad sequestration by MyoX FERM domain. VE-Cad-expressing 
CHO cells (40) were transiently transfected with plasmids coding for GFP-MyoX and either GST-DSR or GST-
FERM-DSR. After cell lysis, Anti-MyoX immunoprecipitations were resolved on 4-12% gradient gels, electro-
transferred and probed successively for VE-Cad, MyoX and GST. As controls, aliquots of the various CHO 
lysates and immunoprecipitations performed using rabbit non-immune IgG (IP Ctr) were analyzed in parallel. 
Molecular markers are given at the margin of each panel. 
  
 
FIG.  14. Functional role of MyoX-mediated transport of VE-Cad. (A) Blockage of VE-CFP transport by GST-
FERM-DSR expression. Subconfluent HUVECs transiently co-transfected with plasmids expressing VE-CFP 
and GST-FERM-DSR were observed 20 h post transfection in phase contrast (I) and in the cyan and red 
fluorescence channels. VE-CFP (II, green), GST-FERM-DSR (III, red), VE-CFP and GST-FERM-DSR merging 
(IV) and VE-CFP and phase contrast merging (V, VI and VII) allowed the visualisation of two adjacent 
differentially-transfected cells: the cell at the right (delimited by yellow dotted line) co-expressed GST-FERM-
DSR and VE-CFP while the cell at the left (delimited by pink dotted line) only expressed VE-CFP.  Other cells 
of the fields are untransfected. The selected enlargements show that VE-CFP patches are at the cell-cell-
junctions (white arrows) and dispersed at the cell surface (white arrow-heads) in monotransfected cell (VI- 
dotted rectangle in V) whereas in the double transfected cell, VE-CFP and GST-FERM-DSR co-localized and 
gathered around the cell nucleus (black arrow-heads, VII- rectangle in V) indicating that GST-FERM-DSR 
blocked the VE-Cad transport to the cell edge. In control experiments, in cells co-expressing GST-DSR and VE-
CFP, VE-CFP patches are located at cell-cell-junctions (data not shown). Bars = 40 µm (I to V); 10 µm (VI and 
VII). (B) Blockage of intercellular contact formation by GST-FERM-DSR expression. The sequences are 
selected from Movie 9 and focus on the edges of two adjacent cells. In the right column, the cell below 
expressed GST-FERM-DSR while the cell at the top is untransfected. In the left column, both cells expressed 
GST-DSR. Arrow-heads show unstable junctions whereas arrows point out stable junctions. Bars = 10 µm. 
  
 
FERM-DSR competes with MyoX for 
interacting with VE-Cad. 
Then, the cellular effect due to VE-Cad 
sequestration by the FERM domain of MyoX 
was analyzed in HUVECs co-expressing VE-
CFP and GST-FERM-DSR. In double-
transfected cells, VE-CFP remained static, 
concentrated at the periphery of the nucleus 
whereas, in absence of GST-FERM-DSR, VE-
CFP appeared highly mobile, disseminated 
over the cell surface and at cell-cell junctions 
(Fig 14 A, See Supplementary data, Movie 
8). We also demonstrated that GST-FERM-
DSR concentrates endogenous VE-Cad in the 
perinuclear area while GST-DSR did not (data 
not shown). It can be deduced that, by 
competing with endogenous MyoX, GST-
FERM-DSR could block the transportation of 
endogenous and exogenous VE-Cad along 
actin fibers. The absence of transport resulted 
in an almost total VE-Cad depletion at cell 
edges (Fig 14 A). Furthermore, cell-cell 
contacts between GST-FERM-DSR-expressing 
cells did not stabilize, in spite of the membrane 
apposition between neighbouring cells (Fig 14 
B, See Supplementary data, Movie 9). 
Numerous intercellular gaps appeared and 
spaces between opposed cells increased with 
time. Hence, blockage of MyoX-mediated VE-
Cad traffic prevents the adhesion between cell 
fronts and formation of early cell-cell contacts 
required for the elaboration of interendothelial 
junctions.  
 
MyoX/VE-Cad co-travelling operates 
during wound healing 
To obtain additional information about the 
cellular role of MyoX/ VE-Cad co-trafficking, 
we performed in vitro wound-healing assays 
on GFP-MyoX- and VE-Cad-DSR- 
overexpressing HUVEC monolayers and 
followed the early steps of cell-cell junction 
reconstruction by phase contrast and 
fluorescence videomicroscopy (See 
Supplementary data, Movie 10). Movie 10 
focused on two non-interacting cells, both co-
expressing VE-DSR and GFP-MyoX. These 
cells emitted very dynamic filopodia. Clearly, 
several of them operated cooperatively in a 
confined area to constitute the first cell-cell 
contacts. At this specific point, it could be 
observed that VE-Cad accumulated at the 
filopodium tips elaborating homophilic 
interactions as soon as filopodia touched the 
neighbouring cell. These very unstable 
preliminary cell-cell contacts initiated the 
formation of filopodium-based bridges 
between the adjacent cells. VE-cadherin-based 
contacts progressively distributed along the 
cell edges. The multiplicity of the contact 
points contributed to cell-cell tightening and to 
the reduction of the intercellular spaces leading 
to a stabilization of the cell-cell junction. In 
conclusion, these data underlined the role 
played by MyoX-mediated accumulation of 
VE-Cad at the tips of filopodia in the 
elaboration of preliminary endothelial cell-cell 




In the present manuscript, we show how the 
actin cytoskeleton supports VE-Cad transport 
along filopodia to eventually elaborate primary 
cell-cell contacts. Indeed, we observed the to- 
and -fro movements of VE-Cad patches along 
filopodia and established that this traffic is 
governed by the motor protein MyoX. A model 
recapitulating VE-Cad movement modes is 
proposed in Fig  15. 
Herein, we observed by immunofluorescent 
staining (Fig 5) and cryo-electron microscopy 
(Fig 6) that VE-Cad is located along filopodia 
emanating from sparse endothelial cells or 
forming bridges between neighbouring cells.  
This contrasts with the usual localization of 
VE-Cad at cell-cell junctions in confluent 
endothelial monolayers. By videomicroscopy, 
we uncovered that VE-Cad navigates along 
these filopodia (Movies 1, 3, 5 and 6) and 
suspected that a motor protein of the myosin 
family might be involved in this traffic. 
Among myosin proteins, myosin-X was a 












FIG. 15. Schematic model illustrating the 
movements of VE-Cad along filopodia (modified 
from (43). MyoX binds to actin filaments via its 
motor domain and to the VE-Cad-catenin complex 
(intra) via its FERM domain. Consequently, VE-
Cad moves forward (F) towards the filopodium tip 
at a rate ranging 700 nm.s-1 and backwards (B) at a 
rate ranging 30 nm.s-1.  
 
This unconventional motor protein is widely 
expressed in a variety of vertebrate tissues in 
particular in vascularised ones such as lung, 
heart and placenta (6). Consistent with this 
observation, MyoX was recently found in the 
endothelium where it is involved in cell 
migration guidance (28). In different cell types, 
it is detected along the leading edge of 
lamellipodia (33) but, more frequently, at the 
tips of filopodia. In fact, MyoX is probably 
involved in the initiation of filopodium 
formation (9, 37). It moves along filopodial 
actin cables by an ATP-dependent walking 
mechanism towards the filament barbed ends, 
but also towards the cell body using the actin 
retrograde flow (5),(6),(26). MyoX possesses a 
FERM domain known to interact with the  β-
chains of integrins (43). Herein, we show that 
MyoX associates, via its FERM domain, with 
the VE-Cad-catenin complex (Fig 9). This 
novel result underlines the versatility of MyoX 
FERM domain for interacting with different 
adhesive receptors.  
We visualized the synchronous transit of 
MyoX and VE-Cad to or from the tips of 
filopodia. The forward movement that reflects 
the barbed end-directed movement of MyoX 
occurs at an average velocity of 700 nm.s-1 
(Fig 11), a value similar to that reported in the 
literature (21). This is also consistent  with the 
500 nm.s-1 rate of the recombinant MyoX head 
moving on actin filaments in vitro (20). This 
similitude between in vivo and in vitro 
velocities indicates that the rate of MyoX 
motion is not affected by the transport of 
cargoes as heavy as the VE-Cad-catenin 
complex. The backward movement exhibits a 
mean rate of 27 nm.s-1 and allows the 
redistribution of VE-Cad at the cell body 
membrane. This motion is probably coupled to 
the continuous actin retrograde flow that 
causes the net transport of actin molecules 
within filaments from the plus end at the tip of 
a filopodium towards the minus end at the cell 
body. The speed of VE-Cad retrograde 
movement matches the speed for actin 
retrograde flow that is approximately 33 nm.s-1 
(32). Moreover, it could be noticed that the 
forward and backward movements are 
frequently interrupted by pausing events.  They 
can be interpreted as the detaching of MyoX 
from actin cables or as the transient 
harpooning of either MyoX or its VE-Cad 
cargo by proteins in their close vicinity.    
In Movie 10, we showed that cells sound 
their environment by emitting filopodia that 
propel VE-Cad molecules against 
neighbouring cells. At these contact sites, VE-
Cad elaborates homophilic interactions with 
VE-Cad partner molecules present in the 
counter membranes to constitute the first cell-
cell anchor points. Subsequently, intercellular 
bridges between adjoining cells form and 
additional VE-Cad molecules transit on them 
prior to be engaged in their turn in homophilic 
interactions. VE-Cad accumulation thus 
reinforces the strength of these preliminary 
contacts. 
VE-Cad molecules on their way back to the 
cell edges may be picked up again by other 
growing filopodia. These to-and-fro 
movements may adjust the local concentration 
of VE-Cad to the cell needs in specific sites 
where cell-cell contacts are constructed or 
remodelled. Moreover, blockage of MyoX-
mediated transport by a dominant-negative 
approach prevents the transportation of VE-
Cad at the plasma membrane and 
subsequently, inhibited formation of 
endothelial cell-cell contacts (Fig 14 A and B). 
Once engaged in homophilic interactions, we 
frequently observed that VE-Cad moved along 
cortical actin fibers thus assisting the lateral 
extension of cell-cell contacts (data not 
shown). At these more mature adhesion cell-
cell contact sites, no co-localization of MyoX 
and VE-Cad was detected suggesting that this 
motor protein is an effective partner for VE-
Cad within filopodia but not in mature 
junctions (Fig 8). This probably reflects the 
heterogeneity existing between the actin 
filaments inserted into filopodia and those 
decorating cell-cell junctions that form, in 
endothelial cells, a continuous thin belt (Fig 5). 
This feature is in agreement with the existence 
of regioselective actin filament populations on 
which some myosins are recruited and other 
ones excluded (10).  
MyoX-mediated accumulation of VE-Cad at 
filopodium tips is an important event probably 
involved in the restoration of endothelial 
monolayer integrity or in reclosure of wounds 
(Movie 10). The multiplicity of cell-cell 
contacts created by filopodia that form bridges 
between adjacent cells seems to participate in 
the stabilization of nascent cell-cell junctions. 
In conclusion, we showed here that MyoX 
transports VE-Cad, an endothelial specific 
cadherin to the tips of filopodia to promote 
homotypic cell-cell junction formation. A 
major goal for the future will be to examine 
whether this MyoX-supported transport of VE-
Cad participates in the endothelium 
remodeling in vivo, in pathophysiological 
situations including endothelium repair or 
angiogenesis. In addition, it will be interesting 
to determine whether the concept of myosin- 
mediated transport of cadherins can be 
extended to tissues expressing other members 




We are indebted to the staff of the maternity from Hôpital Nord (Grenoble, France) for kindly collecting 
umbilical cords. This work was supported by the « Ligue Régionale de Savoie Contre le Cancer », the « Agence 
Nationale de la Recherche » (ANR, PCV) and the « Association pour la Recherche sur le Cancer » (grants N° 
4447 and 3775). S.A. was a recipient of fellowships from the « Commissariat à l’Energie Atomique » (CEA) and 
the «Agence Nationale de Recherche ». A.C.-P., S. H. and M.D. are recipients of fellowships from the CEA, the 
«Association de Recherche sur la Polyarthrite» and the «Agence Nationale de Recherche » (ANR-06-PCV). 
respectively. The optical microscopy - cell imaging plate-form and the Institute Albert Bonniot are 
acknowledged for granting access to the confocal microscopy facilities, help in image acquisition and analysis. 
The authors thank R.E. Cheney for GFP-Myoxin-X, R.-M. Mège and R.Y. Tsien for DSRed cDNA constructs 
and L. Blanchoin for helpful discussions.  
Author contributions: S.A, figures 1, 3, 4 and from 7-15 and all movies; C.D. and S.H., figure 5; A.C.-P., figure 
2; O.L. and M.D., figure 6. J.P.S. provided human umbilical cords; P.H. is the head of the laboratory and 
provided grants, equipments and discussions whereas E.H. helped writing this article; D.G.-D. conceived 




1. Aberle, H., A. Bauer, J. Stappert, A. Kispert, 
and R. Kemler. 1997. beta-catenin is a target for 
the ubiquitin-proteasome pathway. EMBO J 
16:3797-804. 
2. Adams, C. L., Y. T. Chen, S. J. Smith, and W. 
J. Nelson. 1998. Mechanisms of epithelial cell-
cell adhesion and cell compaction revealed by 
high-resolution tracking of E-cadherin-green 
fluorescent protein. J Cell Biol 142:1105-19. 
3. Adams, C. L., W. J. Nelson, and S. J. Smith. 
1996. Quantitative analysis of cadherin-catenin-
actin reorganization during development of cell-
cell adhesion. J Cell Biol 135:1899-911. 
4. Bear, J. E., and F. B. Gertler. 2009. Ena/VASP: 
towards resolving a pointed controversy at the 
barbed end. J Cell Sci 122:1947-53. 
5. Berg, J. S., and R. E. Cheney. 2002. Myosin-X 
is an unconventional myosin that undergoes 
intrafilopodial motility. Nat Cell Biol 4:246-50. 
6. Berg, J. S., B. H. Derfler, C. M. Pennisi, D. P. 
Corey, and R. E. Cheney. 2000. Myosin-X, a 
novel myosin with pleckstrin homology domains, 
associates with regions of dynamic actin. J Cell 
Sci 113 Pt 19:3439-51. 
7. Block, J., T. E. Stradal, J. Hanisch, R. Geffers, 
S. A. Kostler, E. Urban, J. V. Small, K. 
Rottner, and J. Faix. 2008. Filopodia formation 
induced by active mDia2/Drf3. J Microsc 
231:506-17. 
8. Bogatcheva, N. V., and A. D. Verin. 2008. The 
role of cytoskeleton in the regulation of vascular 
endothelial barrier function. Microvasc Res 
76:202-7. 
9. Bohil, A. B., B. W. Robertson, and R. E. 
Cheney. 2006. Myosin-X is a molecular motor 
that functions in filopodia formation. Proc Natl 
Acad Sci U S A 103:12411-6. 
10. Brawley, C. M., and R. S. Rock. 2009. 
Unconventional myosin traffic in cells reveals a 
selective actin cytoskeleton. Proc Natl Acad Sci 
U S A 106:9685-90. 
11. Breviario, F., L. Caveda, M. Corada, I. 
Martin-Padura, P. Navarro, J. Golay, M. 
Introna, D. Gulino, M. G. Lampugnani, and E. 
Dejana. 1995. Functional properties of human 
vascular endothelial cadherin (7B4/cadherin-5), 
an endothelium-specific cadherin. Arterioscler 
Thromb Vasc Biol 15:1229-39. 
12. Campbell, R. E., O. Tour, A. E. Palmer, 
P. A. Steinbach, G. S. Baird, D. A. Zacharias, 
and R. Y. Tsien. 2002. A monomeric red 
fluorescent protein. Proc Natl Acad Sci U S A 
99:7877-82. 
13. Coue, M., S. L. Brenner, I. Spector, and 
E. D. Korn. 1987. Inhibition of actin 
polymerization by latrunculin A. FEBS Lett 
213:316-8. 
14. Erdbruegger, U., M. Haubitz, and A. 
Woywodt. 2006. Circulating endothelial cells: a 
novel marker of endothelial damage. Clin Chim 
Acta 373:17-26. 
15. Faix, J., D. Breitsprecher, T. E. Stradal, 
and K. Rottner. 2009. Filopodia: Complex 
models for simple rods. Int J Biochem Cell Biol 
41:1656-64. 
16. Gulino, D., E. Delachanal, E. Concord, 
Y. Genoux, B. Morand, M. O. Valiron, E. 
Sulpice, R. Scaife, M. Alemany, and T. Vernet. 
1998. Alteration of endothelial cell monolayer 
integrity triggers resynthesis of vascular 
endothelium cadherin. J Biol Chem 273:29786-
93. 
17. Gupton, S. L., and F. B. Gertler. 2007. 
Filopodia: the fingers that do the walking. Sci 
STKE 2007:re5. 
18. Hermant, B., S. Bibert, E. Concord, B. 
Dublet, M. Weidenhaupt, T. Vernet, and D. 
Gulino-Debrac. 2003. Identification of proteases 
involved in the proteolysis of vascular 
endothelium cadherin during neutrophil 
transmigration. J Biol Chem 278:14002-12. 
19. Heyraud, S., M. Jaquinod, C. Durmort, 
E. Dambroise, E. Concord, J. P. Schaal, P. 
Huber, and D. Gulino-Debrac. 2008. 
Contribution of annexin 2 to the architecture of 
mature endothelial adherens junctions. Mol Cell 
Biol 28:1657-68. 
20. Homma, K., J. Saito, R. Ikebe, and M. 
Ikebe. 2001. Motor function and regulation of 
myosin X. J Biol Chem 276:34348-54. 
21. Kerber, M. L., D. T. Jacobs, L. 
Campagnola, B. D. Dunn, T. Yin, A. D. Sousa, 
O. A. Quintero, and R. E. Cheney. 2009. A 
Novel Form of Motility in Filopodia Revealed by 
Imaging Myosin-X at the Single-Molecule Level. 
Curr Biol. 
22. Lampugnani, M. G., M. Resnati, M. 
Raiteri, R. Pigott, A. Pisacane, G. Houen, L. P. 
Ruco, and E. Dejana. 1992. A novel 
endothelial-specific membrane protein is a 
marker of cell-cell contacts. J Cell Biol 
118:1511-22. 
23. Maddugoda, M. P., M. S. Crampton, A. 
M. Shewan, and A. S. Yap. 2007. Myosin VI 
and vinculin cooperate during the morphogenesis 
of cadherin cell cell contacts in mammalian 
epithelial cells. J Cell Biol 178:529-40. 
24. Mallavarapu, A., and T. Mitchison. 
1999. Regulated actin cytoskeleton assembly at 
filopodium tips controls their extension and 
retraction. J Cell Biol 146:1097-106. 
25. Martel, V., L. Vignoud, S. Dupe, P. 
Frachet, M. R. Block, and C. Albiges-Rizo. 
2000. Talin controls the exit of the integrin alpha 
5 beta 1 from an early compartment of the 
secretory pathway. J Cell Sci 113 ( Pt 11):1951-
61. 
26. Mattila, P. K., and P. Lappalainen. 
2008. Filopodia: molecular architecture and 
cellular functions. Nat Rev Mol Cell Biol 9:446-
54. 
27. Mege, R. M., J. Gavard, and M. 
Lambert. 2006. Regulation of cell-cell junctions 
by the cytoskeleton. Curr Opin Cell Biol 18:541-
8. 
28. Pi, X., R. Ren, R. Kelley, C. Zhang, M. 
Moser, A. B. Bohil, M. Divito, R. E. Cheney, 
and C. Patterson. 2007. Sequential roles for 
myosin-X in BMP6-dependent filopodial 
extension, migration, and activation of BMP 
receptors. J Cell Biol 179:1569-82. 
29. Pollard, T. D. 2007. Regulation of actin 
filament assembly by Arp2/3 complex and 
formins. Annu Rev Biophys Biomol Struct 
36:451-77. 
30. Raich, W. B., C. Agbunag, and J. 
Hardin. 1999. Rapid epithelial-sheet sealing in 
the Caenorhabditis elegans embryo requires 
cadherin-dependent filopodial priming. Curr Biol 
9:1139-46. 
31. Rudini, N., and E. Dejana. 2008. 
Adherens junctions. Curr Biol 18:R1080-2. 
32. Schelhaas, M., H. Ewers, M. L. 
Rajamaki, P. M. Day, J. T. Schiller, and A. 
Helenius. 2008. Human papillomavirus type 16 
entry: retrograde cell surface transport along 
actin-rich protrusions. PLoS Pathog 4:e1000148. 
33. Sousa, A. D., J. S. Berg, B. W. 
Robertson, R. B. Meeker, and R. E. Cheney. 
2006. Myo10 in brain: developmental regulation, 
identification of a headless isoform and dynamics 
in neurons. J Cell Sci 119:184-94. 
34. Svitkina, T. M., E. A. Bulanova, O. Y. 
Chaga, D. M. Vignjevic, S. Kojima, J. M. 
Vasiliev, and G. G. Borisy. 2003. Mechanism of 
filopodia initiation by reorganization of a 
dendritic network. J Cell Biol 160:409-21. 
35. Tesfamariam, B., and A. F. DeFelice. 
2007. Endothelial injury in the initiation and 
progression of vascular disorders. Vascul 
Pharmacol 46:229-37. 
36. Tokuo, H., and M. Ikebe. 2004. Myosin 
X transports Mena/VASP to the tip of filopodia. 
Biochem Biophys Res Commun 319:214-20. 
37. Tokuo, H., K. Mabuchi, and M. Ikebe. 
2007. The motor activity of myosin-X promotes 
actin fiber convergence at the cell periphery to 
initiate filopodia formation. J Cell Biol 179:229-
38. 
38. Vasioukhin, V., C. Bauer, M. Yin, and 
E. Fuchs. 2000. Directed actin polymerization is 
the driving force for epithelial cell-cell adhesion. 
Cell 100:209-19. 
39. Vasioukhin, V., and E. Fuchs. 2001. 
Actin dynamics and cell-cell adhesion in 
epithelia. Curr Opin Cell Biol 13:76-84. 
40. Wallez, Y., F. Cand, F. Cruzalegui, C. 
Wernstedt, S. Souchelnytskyi, I. Vilgrain, and 
P. Huber. 2007. Src kinase phosphorylates 
vascular endothelial-cadherin in response to 
vascular endothelial growth factor: identification 
of tyrosine 685 as the unique target site. 
Oncogene 26:1067-77. 
41. Waschke, J., F. E. Curry, R. H. 
Adamson, and D. Drenckhahn. 2005. 
Regulation of actin dynamics is critical for 
endothelial barrier functions. Am J Physiol Heart 
Circ Physiol 288:H1296-305. 
42. Wood, W., and P. Martin. 2002. 
Structures in focus--filopodia. Int J Biochem Cell 
Biol 34:726-30. 
43. Zhang, H., J. S. Berg, Z. Li, Y. Wang, P. 
Lang, A. D. Sousa, A. Bhaskar, R. E. Cheney, 
and S. Stromblad. 2004. Myosin-X provides a 
motor-based link between integrins and the 
cytoskeleton. Nat Cell Biol 6:523-31. 
 
 
 















